News | Archive | 2019

QUE Oncology recruiting Sydney breast cancer patients experiencing hot flushes & night sweats
Posted: 2019-10-23 in Press Releases


$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease
Posted: 2019-09-26 in Press Releases


Q-Sera’s innovative blood clotting technology granted patent in US
Posted: 2019-08-20 in Press Releases


QUE Oncology launches Phase II trials in New Zealand
Posted: 2019-08-01 in Press Releases


QUE Oncology Appoints Dr. Julie Cherrington and Elizabeth Cermak to Board of Directors
Posted: 2019-07-29 in Press Releases


PolyActiva completes recruitment in key Phase I glaucoma implant safety study.
Posted: 2019-07-23 in Press Releases


Morphoseq™ at ‘Sequencing, Finishing and Analysis in the Future’ meeting, USA
Posted: 2019-05-22 in Press Releases


Longas Launches, Unveiling Morphoseq™ Long Read DNA Sequencing Technology
Posted: 2019-05-16 in Press Releases


Bandon Capital Partners launches new Medical Research Commercialisation Fund, seeks NZ institutional
Posted: 2019-05-01 in Press Releases


QUE Oncology launches Phase II trials in the United States
Posted: 2019-04-02 in Press Releases


MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis
Posted: 2019-03-15 in Press Releases


Aravax reveals positive Phase I trial results at world-leading allergy conference
Posted: 2019-02-25 in Press Releases


Australian Phase II trial commences for potential world-first treatment of viral conjunctivitis
Posted: 2019-01-31 in Press Releases